From: Is higher lymphocyte count a potential strategy for preventing chronic kidney disease in patients receiving long-term dasatinib treatment?
Variable
Odds ratio (95% CI)
p-value
Age (years)
1.073 (0.999–1.153)
0.054
Maximal lymphocyte count (/μL)
0.999 (0.999–1.000)
0.033